Palbace 125mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Palbociclib (125mg)
Overview Palbace 125mg Tablet
Ribociclib 125mg tablets are indicated for treating metastatic estrogen receptor-positive, HER2-negative breast cancer in conjunction with endocrine therapy. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your individual treatment needs and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper use or overdose can result in severe adverse reactions. Therapeutic effects may not be apparent for several weeks or months; discontinue use only as directed by your doctor. Common side effects include weariness, alopecia, skin rashes, emesis, and diarrhea. This medication can cause cytopenia, increasing infection risk; report any signs of infection (fever, chills, malaise), bleeding, or dizziness to your physician. Dizziness may impair driving ability and necessitate avoidance of tasks requiring alertness. Prior to initiating treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all current medications, including antibiotics, to your doctor; significant drug interactions are possible. This medication is contraindicated in pregnancy and lactation. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Palbace 125mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Palbace 125mg Tablet
Malignant breast tumor
Major Benefits of Palbace 125mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 125mg Palbace Tablet whole; avoid crushing, chewing, or fracturing it. It should be taken with a meal.
Common Side effects of Palbace 125mg Tablet:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Palbace 125mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Palbace 125mg Tablet should be administered with a meal.
How Palbace 125mg Tablet works:
Palbace 125mg tablets function as an anti-neoplastic agent. Its mechanism involves blocking cyclin-dependent kinases 4 and 6, key proteins in cellular proliferation pathways. This inhibition halts the cancerous cell cycle's progression. Furthermore, it specifically targets estrogen receptor-positive breast cancer cells by interfering with their cell growth processes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Palbace 125mg Tablet may pose safety risks; physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Palbace 125mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in emergencies where the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Using Palbace 125mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Palbace 125mg Tablets, as they can induce fatigue in certain individuals. If fatigue occurs, operating machinery or driving requires extra care.
KidneySAFE IF PRESCRIBED
In patients with kidney impairment, Palbace 125mg tablets are considered safe and require no dosage modification.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Palbace 125mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Palbace 125mg Tablet :
NA
Facts to Know About Palbace 125mg Tablet
Label | Value |
---|---|
Chemical Category | Piperazine-pyridines |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Actions | CDK Inhibitor |